Friday, March 12, 2010
"Concise industry news from the US pharmaceutical industry..."
Out from the shadows - Why the rapid rise of emerging markets will change the pharmaceutical world as we know it.
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Marie Shields
Editor NGP US
Editor NGP US
Sizing up the future
What role will individually tailored therapies play in the pharmaceutical industry’s new business models?01 Oct 2009
You need adobe flash player to view this content
Latest News
-
Abbott Labs buy Facet Biotech
International pharmaceutical healthcare company Abbott Laboratories has confirmed today that it will acquire Facet Biotech Corp for $27 a share. This equates to a total purchase...Read more
03/11/2010 15:59
Comments -
Snake venom could help drug discovery
According to a new report, snake venom could be used to advance drug discovery. The claim, which is made by researchers at the University of Singapore, says that venom contains...Read more
03/09/2010 18:18
Comments -
FDA pledges more criminal prosecutions
The FDA has this morning announced plans to increase criminal prosecutions of "responsible corporate officials," according agency Commissioner Margaret Hamburg.Read more
03/08/2010 07:56
Comments -
FDA told to investigate digital marketers
The Center for Digital Democracy has urged the FDA to investigate how pharmaceutical companies are making use of digital marketing techniques, citing that the US consumer should...Read more
03/04/2010 16:06
Comments -
Pfizer job cuts continue
Global pharmaceutical giant Pfizer laid off 201 employees at the end of last week, as the company moved to close three local facilities and reduce staff at a fourth...Read more
03/02/2010 16:08
Comments -
FDA deal to fast-track new drugs
A new partnership between the FDA and the NIH aimed at speeding up public access to innovative medicines have been welcomed by US industry leaders.Read more
03/01/2010 17:49
Comments
Editor’s Choice
-
The lean solution
Carmen Doran of Novartis Pharma Technical Operations explains how the unique combination of Lean and Six Sigma is bringing about significant performance improvements through the...Read more -
Wedded bliss?
NGP talks to GSK’s Paul Matthews about the unique challenges posed by the marriage of imaging and drug development.Read more -
Fixing the failure rate
Celgene Corporation’s Kamal Shah looks at why most new drug compounds fail to progress beyond the clinical trial stage.Read more -
Business minded
Raafat Fahim of Nabi Biopharmaceuticals explains why a more efficient business model is needed to cope with the increasing challenges within the industry.Read more -
Who influenced WHO?
Is it better to overestimate the threat of a virus and spend millions on vaccines that may not be needed, or make a misjudgment in the other direction and cause millions of...Read more -
The pharmaceutical supply chain
Tightening the security of the pharmaceutical supply chain is becoming a key issue for the industry. The fight to avoid contaminated ingredients finding their way into medicines...Read more
Readers’ Choice
-
Breaking New Ground
Sean Harper tells NGP why he is excited about potential new treatments for osteoporosis, why animal models aren't always useful in developing drugs for humans, and why the...Read more -
Customer Centric Service: The New Rx fo...
As the industry moves from its traditional sales and marketing approach to customer centric service models, companies are seeking to better meet physicians’ need for product,...Read more -
In with the New
When Chris Viehbacher arrived to take up the reins as CEO of sanofi-aventis, he found a company with an image problem that had forgotten how to communicate. Now he plans to...Read more -
Pharmaceutical Marketing After the Gold ...
Targeted Analytics Become Keys to a Lean, Mean Branding Machine By Mukesh Mehta, RPhRead more -
Early Phase Research – The Problem, the ...
Members of product development teams typically visit the Phase I-II world every few years. Increasingly, however, they are finding it a different world at each visit, due to a...Read more -
The Enterprise Lab Notebook
Enabling multi-disciplinary virtual teams to improve R&D productivity through knowledge sharing. By Symyx Technologies, Inc.Read more
Executive Interviews
Real-time data for manufacturing
Craig Dobbs of Waters describes definitive technologies for PAT and QbD initiatives.
Read more
Understanding the new prescribing influences
Tom Haskell and John Moran of IMS’ Innovation Lab discuss how to evaluate new factors driving prescribing decisions.
Read more
Rise of biologics
Nitin Sood of Agilent Automation Solutions explains the expansion of automation trends in life sciences.
Read more
Next Generation Healthcare Summit 2010
11th - 13th May
As healthcare costs continue to rise, health providers around the country feel a sharp sense of urgency in deploying information technology to lower costs, reduce medical errors, enhance outcomes, and spur efficiency in an industry known for legendary inefficiency.
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.